Clinical trials
Phase 2 Bacteremia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2014 | 1 |
| 2017 | 4 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 4 |
| Unknown status | 3 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 1 |
| Anderson Clinical Research | 1 |
| Basilea Pharmaceutica | 1 |
| Bristol-Myers Squibb | 1 |
| ContraFect | 1 |
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Duke University | 1 |
| LigaChem Biosciences, Inc. | 1 |
| M.D. Anderson Cancer Center | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bacteremia | 20 |
| Staphylococcal Infections | 7 |
| Sepsis | 4 |
| Endocarditis | 3 |
| Infections | 3 |
| AIDS-Related Opportunistic Infections | 1 |
| Bronchopulmonary Dysplasia | 1 |
| Chronic Periodontitis | 1 |
| Communicable Diseases | 1 |
| Endocarditis, Bacterial | 1 |
Trials
Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.